Tobramycin Given in Nanoparticles May Best Treat P. aeruginosa

Tobramycin Given in Nanoparticles May Best Treat P. aeruginosa

294428

Tobramycin Given in Nanoparticles May Best Treat P. aeruginosa

A new biomaterial made up of nanoparticles showed a potential to improve — by up to 100,000 times — the efficiency of tobramycin, an antibiotic used to treat cystic fibrosis (CF) patients with Pseudomonas aeruginosa infections. Tobramycin, carried within a nanostructured material, completely eradicated P. aeruginosa infection in a model of CF bronchial epithelial cells after two doses. “Tobramycin is commonly used to treat these infections but increasingly antibiotics are failing to make any significant difference to…

You must be logged in to read/download the full post.